0QUT.LSE Episurf Medical AB Series B

Healthcare Oil, Gas & Consumable Fuels London Exchange
- SEK
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2022.

Is 0QUT.LSE undervalued?

Graham number

The Graham number of Episurf Medical AB Series B cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Episurf Medical AB Series B fundamental analysis

No fundamental analysis for Episurf Medical AB Series B yet.

Episurf Medical AB Series B stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Episurf Medical AB Series B

Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It provides Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient's knee joint; Episealer implant, which is designed to fit anatomy and size of the lesion; Episealer toolkit; and Episealer Patellofemoral System, a system to treat o…

Full company profile